Patents Assigned to IRM LLC (a Delaware Limited Liability Corporation)
  • Compounds and compositions as protein kinase inhibitors
    Patent number: 7423038
    Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders than involve abnormal activation of the Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3?, IR, JNK1? 1, JNK2? 2, Lck, MKK4, MKK6, p70S6K, PDGFR?, Rsk1, SAPK2?, SAPK2?, Syk and Trk? kinases.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: September 9, 2008
    Assignee: IRM LLC (a Delaware Limited Liability Corporation)
    Inventors: Pingda Ren, Xia Wang, Nathanael Schiander Gray, Yi Liu, Taebo Sim